Copenhagen, Denmark

Daryl Grant Humes

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Hvidovre Hospital. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daryl Grant Humes. Retrieved from https://idiyas.com/inventor/daryl-grant-humes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Daryl Grant Humes: Innovator in Hepatitis C Research

Introduction

Daryl Grant Humes is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of hepatitis C research, particularly in the development of culture systems that aid in drug and vaccine development.

Latest Patents

Humes holds a patent for "HCV culture systems and direct-acting antiviral sensitivity." This invention relates to hepatitis C virus (HCV) culture systems of genotypes 1a, 3a, 4a, 5a, and 6a. It directly contributes to HCV drug and vaccine development, basic research, and better-individualized treatment for HCV-infected patients. He has 1 patent to his name.

Career Highlights

Daryl Grant Humes is affiliated with Hvidovre Hospital, where he applies his expertise in hepatitis C research. His work has been instrumental in advancing the understanding and treatment of this viral infection.

Collaborations

Humes collaborates with esteemed colleagues, including Yiping Li and Santseharay Ramirez Almeida, to further enhance research efforts in the field of hepatitis C.

Conclusion

Daryl Grant Humes is a pioneering inventor whose work in hepatitis C research is making a significant impact on drug and vaccine development. His contributions are vital for improving treatment options for patients affected by this virus.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…